Cite
MLA Citation
Rebecca S Heist et al.. “CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY.” Neuro-oncology, vol. 21, n.d., p. vi56. http://access.bl.uk/ark:/81055/vdc_100101668105.0x000034